Earnings Preview: Boston Scientific 2 comments
February 04, 2008
| about: BSX
-
Font Size:
-
Print
- TweetThis
Boston Scientific (BSX) is scheduled to report Q4 earnings
with a conference call scheduled for 8:30 a.m. ET, Tuesday, February 5th.
Analysts are expecting
a profit of 8c on revenue of $2.13B. The consensus range for EPS is
(12c) to 12c, with a revenue range of $2.09B to $2.17B, according to
First Call. EPS expectations for this quarter are lower than its year
over year results of 10c. Last month, company CEO Paul LaViolette said
his 2008 goal is to have 3% to 5% revenue and 18% to 20% EPS growth.
Also, that the biggest boost to the bottom line will come from cost
cutting.
Guidance
Analysts are expecting
a profit of 8c on revenue of $2.13B. The consensus range for EPS is
(12c) to 12c, with a revenue range of $2.09B to $2.17B, according to
First Call. EPS expectations for this quarter are lower than its year
over year results of 10c. Last month, company CEO Paul LaViolette said
his 2008 goal is to have 3% to 5% revenue and 18% to 20% EPS growth.
Also, that the biggest boost to the bottom line will come from cost
cutting.
Analyst Views
Morgan Stanley upgraded the stock to Overweight from Equal Weight, and set a price target of $15 per share, saying that all downside threats to the stock are priced in, but none of the "dramatic" cost cutting initiatives are factored. Also, that sales of stents and implantable heart devices may be better than expected. The stock was upgraded by Banc of America to Neutral from Buy, saying restructuring and new products will lead to larger profits in 2009 forward.
Related Articles
|


























This article has 2 comments: